Product Surveillance Registry

NCT01524276 · tracked via the Priya Life Science Germany tracker

Sponsor

Medtronic

Phase

Observational

Started

2012-01

Last updated

2026-09-18

Condition(s) studied

Cardiac Rhythm DisordersUrological DisordersNeurological DisordersCardiovascular DisordersDigestive DisordersIntracranial AneurysmMechanical Circulatory SupportRespiratory TherapyAortic, Peripheral Vascular and Venous DisordersMinimally Invasive Surgical ProceduresDiagnostic Techniques and ProceduresSurgical Procedures, OperativeRenal InsufficiencyNeurovascularCoronary Artery DiseaseEar, Nose and Throat Disorder

Study summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment Exclusion Criteria: * Patient who is, or will be, inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Primary outcome measure(s)

Safety and Effectiveness of Market Released products — Every 6-12 months (Therapy-dependent)

Trial sites (401)

Facility	City	Region	Status
—	Birmingham	Alabama	Recruiting
—	Huntsville	Alabama	Recruiting
—	Chandler	Arizona	Recruiting
—	Phoenix	Arizona	Recruiting
—	Little Rock	Arkansas	Recruiting
—	Aliso Viejo	California	Recruiting
—	Chula Vista	California	Recruiting
—	Colton	California	Recruiting
—	La Jolla	California	Recruiting
—	Los Angeles	California	Recruiting
—	Napa	California	Recruiting
—	Redwood City	California	Recruiting
—	Salinas	California	Recruiting
—	San Diego	California	Recruiting
—	Stanford	California	Recruiting
—	Torrance	California	Recruiting
—	Ventura	California	Recruiting
—	Aurora	Colorado	Recruiting
—	Colorado Springs	Colorado	Recruiting
—	Lakewood	Colorado	Recruiting
—	Darien	Connecticut	Recruiting
—	Hartford	Connecticut	Recruiting
—	New Haven	Connecticut	Recruiting
—	Washington D.C.	District of Columbia	Recruiting
—	Bradenton	Florida	Recruiting
—	Clearwater	Florida	Recruiting
—	Davie	Florida	Recruiting
—	Jacksonville	Florida	Recruiting
—	Naples	Florida	Recruiting
—	Panama City	Florida	Recruiting
—	Safety Harbor	Florida	Recruiting
—	Sarasota	Florida	Recruiting
—	Tampa	Florida	Recruiting
—	Weston	Florida	Recruiting
—	Gainesville	Georgia	Active Not Recruiting
—	Chicago	Illinois	Recruiting
—	Evansville	Indiana	Recruiting
—	Indianapolis	Indiana	Recruiting
—	Iowa City	Iowa	Recruiting
—	West Des Moines	Iowa	Recruiting

+ 361 more sites — see the full list on the official registry below.

More Medtronic trials in Germany

Enlighten Study: The EV-ICD Post Approval Registry Active, not recruiting

Micra Transcatheter Pacing System Post-Approval Registry Active, not recruiting

Lead Evaluation for Defibrillation and Reliability Post Approval Study Enrolling by invitation

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting

Other trials for the same condition

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial Active, not recruiting

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial Active, not recruiting

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01524276 on ClinicalTrials.gov ↗ ← All trials in Germany